Imugene will trial PD1-Vaxx in patients with non-small cell lung cancer. Pre-clinical milestones have been met with GMP manufacturing, including final sterile fill and finish as well as processes completed by FDA inspected and qualified contract manufacturing organisations in the US.
ASX: IMU
http://ow.ly/Gzyu50y7IFY
#EndCancer #Biotech #Pharma #LifeSciences #ASX #ClinicalTrials
Latest Facebook Post from IMU
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $276.9K | 5.675M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 81 | 9606156 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2622245 | 26 |
View Market Depth
| Last trade - 12.59pm 09/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |